<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>DESOWEN - desonide cream </strong><br><strong>DESOWEN - desonide lotion </strong><br>Galderma Laboratories, L.P.<br></p></div>
<h1>DesOwen® Rx Only<br>(desonide cream and lotion)<br>cream 0.05%<br>and lotion 0.05%<br><br>For Dermatologic Use Only –<br>Not for Ophthalmic Use –</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
<h1></h1>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="section-1"></a><p></p>
<h1>DESCRIPTION:</h1>
<p class="First">DesOwen<span class="Sup">®</span> Cream 0.05% and Lotion 0.05% contain desonide (Pregna-1,4-diene-3,20-dione,11,21-dihydroxy-16,17 [(1-methylethylidene)bis(oxy)]-,(11β,16α)- a synthetic nonfluorinated corticosteroid for topical dermatologic use. The corticosteroids constitute a class of primarily synthetic steroids used topically as anti-inflammatory and anti-pruritic agents.</p>
<p>Chemically, desonide is C<span class="Sub">24</span>H<span class="Sub">32</span>O<span class="Sub">6</span>. It has the following structural formula:</p>
<p><img alt="desowen-structure-01" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=a7e5f030-b849-4805-94e6-f45631eaa37f&amp;name=desowen-structure-01.jpg"></p>
<p>Desonide has the molecular weight of 416.51. It is a white to off white odorless powder which is soluble in methanol and practically insoluble in water.</p>
<p>Each gram of DesOwen<span class="Sup">®</span> Cream contains 0.5 mg of desonide in a base of citric acid, emulsifying wax, isopropyl palmitate, polysorbate 60, potassium sorbate, propyl gallate, propylene glycol, purified water, sodium hydroxide, sorbic acid, stearic acid, and synthetic beeswax.</p>
<p>Each gram of DesOwen<span class="Sup">®</span> Lotion contains 0.5 mg of desonide in a base of cetyl alcohol, edetate sodium, glyceryl stearate SE, light mineral oil, methylparaben, propylene glycol, propylparaben, purified water, sodium lauryl sulfate, sorbitan monostearate, and stearyl alcohol. May contain citric acid and/or sodium hydroxide for pH adjustment.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="section-2"></a><p></p>
<h1>CLINICAL PHARMACOLOGY:</h1>
<p class="First">Like other topical corticosteroids, desonide has anti-inflammatory, antipruritic and vasoconstrictive properties. The mechanism of the anti-inflammatory activity of the topical steroids, in general, is unclear. However, corticosteroids are thought to act by the induction of phospholipase A<span class="Sub">2</span> inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of <span class="product-label-link" type="condition" conceptid="4053015" conceptname="Inflammation">inflammation</span> such as prostaglandins and leukotrienes by inhibiting the release of their common precursor arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A<span class="Sub">2</span>.</p>
<div class="Section" data-sectionCode="43682-4">
<a name="ID_e7ddf48d-686d-4af9-ea0a-efdc49d90416"></a><a name="section-2.1"></a><p></p>
<h2>Pharmacokinetics:</h2>
<p class="First">The extent of percutaneous absorption of topical corticosteroids is determined by many factors including the vehicle and the integrity of the epidermal barrier. Occlusive dressings with hydrocortisone for up to 24 hours have not been demonstrated to increase penetration; however, occlusion of hydrocortisone for 96 hours markedly enhances penetration. Topical corticosteroids can be absorbed from normal intact skin. <span class="product-label-link" type="condition" conceptid="4053015" conceptname="Inflammation">Inflammation</span> and/or other disease processes in the skin may increase percutaneous absorption.</p>
<p>Studies performed with DesOwen<span class="Sup">®</span> (desonide cream and lotion) Cream and Lotion indicate that they are in the low to medium range of potency as compared with other topical corticosteroids.</p>
</div>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="section-3"></a><p></p>
<h1>INDICATIONS AND USAGE:</h1>
<p class="First">DesOwen<span class="Sup">®</span> Cream and Lotion are low to medium potency corticosteroids indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="section-4"></a><p></p>
<h1>CONTRAINDICATIONS:</h1>
<p class="First">DesOwen<span class="Sup">®</span> Cream and Lotion are contraindicated in those patients with a history of <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to any of the components of the preparations.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="A9517FF2-3D02-40A4-A460-2C99D7987E76"></a><a name="section-5"></a><p></p>
<h1>PRECAUTIONS:</h1>
<div class="Section" data-sectionCode="34072-9">
<a name="section-5.1"></a><p></p>
<h2>General:</h2>
<p class="First">Systemic absorption of topical corticosteroids can produce reversible hypothalamic-pituitary-adrenal (HPA) axis suppression with the potential for glucocorticosteroid insufficiency after withdrawal of treatment. Manifestations of Cushing’s syndrome, <span class="product-label-link" type="condition" conceptid="4214376" conceptname="Hyperglycemia">hyperglycemia</span>, and glucosuria can also be produced in some patients by systemic absorption of topical corticosteroids while on treatment.</p>
<p>Patients applying a topical steroid to a large surface area or to areas under occlusion should be evaluated periodically for evidence of HPA axis suppression. This may be done by using the ACTH stimulation, A.M. plasma cortisol, and urinary free cortisol tests. Patients receiving superpotent corticosteroids should not be treated for more than 2 weeks at a time and only small areas should be treated at any one time due to the increased risk of HPA axis suppression.</p>
<p>If HPA axis suppression is noted, an attempt should be made to withdraw the drug, to reduce the frequency of application, or to substitute a less potent corticosteroid. Recovery of HPA axis function is generally prompt and complete upon discontinuation of topical corticosteroids. Infrequently, signs and symptoms of glucocorticosteroid insufficiency may occur requiring supplemental systemic corticosteroids. For information on systemic supplementation, see prescribing information for those products.</p>
<p>Pediatric patients may be more susceptible to systemic toxicity from equivalent doses due to their larger skin surface to body <span class="product-label-link" type="condition" conceptid="4041088" conceptname="Mass">mass</span> ratios. (See PRECAUTIONS - Pediatric use).</p>
<p>If irritation develops, DesOwen<span class="Sup">®</span> Cream or Lotion should be discontinued and appropriate therapy instituted. <span class="product-label-link" type="condition" conceptid="134438" conceptname="Contact dermatitis">Allergic contact dermatitis</span> with corticosteroids is usually diagnosed by observing <span class="Italics">failure to heal</span> rather than noting a clinical exacerbation as with most topical products not containing corticosteroids. Such an observation should be corroborated with appropriate diagnostic patch testing.</p>
<p>If concomitant <span class="product-label-link" type="condition" conceptid="201093" conceptname="Infection of skin AND/OR subcutaneous tissue">skin infections</span> are present or develop, an appropriate antifungal or antibacterial agent should be used. If a favorable response does not occur promptly, use of DesOwen<span class="Sup">®</span> (desonide cream and lotion) Cream or Lotion should be discontinued until the <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span> has been adequately controlled.</p>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="section-5.2"></a><p></p>
<h2>Information for patients:</h2>
<p class="First">Patients using topical corticosteroids should receive the following information and instructions:</p>
<ol class="Arabic">
<li><p class="First">This medication is to be used as directed by the physician. It is for external use only. Avoid contact with the eyes.</p></li>
<li><p class="First">This medication should not be used for any disorder other than that for which it was prescribed.</p></li>
<li><p class="First">The treated skin area should not be bandaged or otherwise covered or wrapped so as to be occlusive unless directed by the physician.</p></li>
<li><p class="First">Patients should report to their physician any signs of local adverse reactions.</p></li>
</ol>
</div>
<div class="Section" data-sectionCode="34075-2">
<a name="section-5.3"></a><p></p>
<h2>Laboratory tests:</h2>
<p class="First">The following tests may be helpful in evaluating patients for HPA axis suppression:</p>
<p>ACTH stimulation test</p>
<p>A.M. plasma cortisol test</p>
<p>Urinary free cortisol test</p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="section-5.4"></a><p></p>
<h2>Carcinogenesis, mutagenesis, impairment of fertility:</h2>
<p class="First">Long-term animal studies have not been performed to evaluate the carcinogenic potential or the effect on reproduction with the use of DesOwen<span class="Sup">®</span> Cream and Lotion.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="section-5.5"></a><p></p>
<h2>Pregnancy:</h2>
<div class="Section" data-sectionCode="34077-8">
<a name="section-5.5.1"></a><p></p>
<h3></h3>
<p class="First"><span class="Italics">Teratogenic Effects: Pregnancy category C:</span></p>
<p>Corticosteroids have been shown to be teratogenic in laboratory animals when administered systemically at relatively low dosage levels. Some corticosteroids have been shown to be teratogenic after dermal application in laboratory animals. Animal reproduction studies have not been conducted with DesOwen<span class="Sup">®</span> Cream or Lotion. It is also not known whether DesOwen<span class="Sup">®</span> Cream or Lotion can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. DesOwen<span class="Sup">®</span> Cream and Lotion should be given to a pregnant woman only if clearly needed.</p>
</div>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="section-5.6"></a><p></p>
<h2>Nursing mothers:</h2>
<p class="First">Systemically administered corticosteroids appear in human milk and could suppress growth, interfere with endogenous corticosteroid production, or cause other untoward effects. It is not known whether topical administration of corticosteroids could result in sufficient systemic absorption to produce detectable quantities in human milk. Because many drugs are excreted in human milk, caution should be exercised when DesOwen<span class="Sup">®</span> Cream or Lotion is administered to a nursing woman.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="AC8C6C48-0BC4-442C-A9AB-9C713F8846C9"></a><a name="section-5.7"></a><p></p>
<h2>Pediatric use:</h2>
<p class="First">Safety and effectiveness in pediatric patients have not been established. Because of a higher ratio of skin surface area to body <span class="product-label-link" type="condition" conceptid="4041088" conceptname="Mass">mass</span>, pediatric patients are at a greater risk than adults of HPA axis suppression when they are treated with topical corticosteroids. They are therefore also at greater risk of glucocorticosteroid insufficiency after withdrawal of treatment and of Cushing’s syndrome while on treatment. Adverse effects including <span class="product-label-link" type="condition" conceptid="137054" conceptname="Skin striae">striae</span> have been reported with inappropriate use of topical corticosteroids in infants and children.</p>
<p>HPA axis suppression, Cushing’s syndrome, linear <span class="product-label-link" type="condition" conceptid="4245750" conceptname="Growth retardation">growth retardation</span>, delayed <span class="product-label-link" type="condition" conceptid="4134784" conceptname="Weight increased">weight gain</span> and <span class="product-label-link" type="condition" conceptid="4154803" conceptname="Raised intracranial pressure">intracranial hypertension</span> have been reported in children receiving topical corticosteroids. Manifestations of adrenal suppression in children include low plasma cortisol levels, and absence of response to ACTH stimulation. Manifestations of <span class="product-label-link" type="condition" conceptid="4154803" conceptname="Raised intracranial pressure">intracranial hypertension</span> include bulging fontanelles, <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headaches</span>, and bilateral <span class="product-label-link" type="condition" conceptid="4308632" conceptname="Optic disc edema">papilledema</span>.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="section-6"></a><p></p>
<h1>ADVERSE REACTIONS:</h1>
<p class="First">In controlled clinical trials, the total incidence of adverse reactions associated with the use of desonide was approximately 8%. These were: <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">stinging</span> and burning approximately 3%, irritation, <span class="product-label-link" type="condition" conceptid="134438" conceptname="Contact dermatitis">contact dermatitis</span>, condition worsened, <span class="product-label-link" type="condition" conceptid="4032013" conceptname="Desquamation">peeling</span> of skin, <span class="product-label-link" type="condition" conceptid="4302654" conceptname="Itching">itching</span>, intense transient <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">erythema</span>, and dryness/scaliness, each less than 2%.</p>
<p>The following additional local adverse reactions have been reported infrequently with other topical corticosteroids, and they may occur more frequently with the use of occlusive dressings, especially with higher potency corticosteroids. These reactions are listed in an approximate decreasing order of occurrence: <span class="product-label-link" type="condition" conceptid="4029295" conceptname="Folliculitis">folliculitis</span>, <span class="product-label-link" type="condition" conceptid="4299558" conceptname="Acneiform eruption">acneiform eruptions</span>, hypopigmentation, <span class="product-label-link" type="condition" conceptid="135032" conceptname="Dermatitis due to substances taken internally">perioral dermatitis</span>, <span class="product-label-link" type="condition" conceptid="442777" conceptname="Generalized infection during labor">secondary infection</span>, <span class="product-label-link" type="condition" conceptid="134118" conceptname="Atrophic condition of skin">skin atrophy</span>, <span class="product-label-link" type="condition" conceptid="137054" conceptname="Skin striae">striae</span>, and <span class="product-label-link" type="condition" conceptid="4273714" conceptname="Miliaria">miliaria</span>.</p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="section-7"></a><p></p>
<h1>OVERDOSAGE:</h1>
<p class="First">Topically applied DesOwen<span class="Sup">®</span> (desonide cream and lotion) Cream and Lotion can be absorbed in sufficient amounts to produce systemic effects (See PRECAUTIONS).</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="section-8"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION:</h1>
<p class="First">DesOwen<span class="Sup">®</span> Cream or Lotion should be applied to the affected areas as a thin film two or three times daily depending on the severity of the condition. SHAKE LOTION WELL BEFORE USING.</p>
<p>As with other corticosteroids, therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary.</p>
<p>DesOwen<span class="Sup">®</span> Cream and Lotion should not be used with occlusive dressings.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="section-9"></a><p></p>
<h1>HOW SUPPLIED:</h1>
<p class="First">DesOwen<span class="Sup">®</span> (desonide cream) Cream 0.05% is supplied in a tube containing:</p>
<p>60 g <span class="Bold">NDC</span> 0299-5770-60</p>
<p>15 g <span class="Bold">NDC</span> 0299-5770-15</p>
<p>DesOwen<span class="Sup">®</span> (desonide lotion) Lotion 0.05% is supplied in bottles containing:</p>
<p>2 fl oz <span class="Bold">NDC</span> 0299-5765-02</p>
<p>4 fl oz <span class="Bold">NDC</span> 0299-5765-04</p>
<p><span class="Bold">Storage Conditions:</span> Store between 2° and 30°C (36° and 86°F).</p>
<p>Marketed by:<br>GALDERMA LABORATORIES, L.P.<br>Fort Worth, Texas 76177, USA<br>GALDERMA is a registered trademark.<br>P52472-0 Revised: May 2014</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="ID_a52a72de-4716-ea30-a6eb-74060f874ef7"></a><a name="section-10"></a><p></p>
<h1>PACKAGE LABEL</h1>
<p class="First"><span class="Bold"><img alt="p52473-0-desowen-cream-60g-carton" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=a7e5f030-b849-4805-94e6-f45631eaa37f&amp;name=p52473-0-desowen-cream-60g-carton.jpg"></span></p>
<p><span class="Bold">NDC 0299-5770-60</span></p>
<p><span class="Bold">Rx Only</span></p>
<p><span class="Bold">DesOwen<span class="Sup">®</span></span></p>
<p><span class="Bold">(desonide cream)</span></p>
<p><span class="Bold">Cream 0.05% NET WT. 60 g</span></p>
<p><span class="Bold">GALDERMA</span></p>
<p><span class="Bold">For External Use Only. Not for Ophthalmic Use.</span> Store between 2° and 30°C (35° and 86°F).</p>
<p><span class="Bold">Usual dosage:</span> Apply a small amount to affected areas 2 or 3 times daily. See package insert for complete prescribing information.</p>
<p><span class="Bold">Each gram contains </span>0.5 mg of the <span class="Bold">active</span> ingredient desonide in a cream base consisting of the <span class="Bold">inactive</span> ingredients citric acid, emulsifying wax, isopropyl palmitate, polysorbate 60, potassium sorbate, propyl gallate, propylene glycol, purified water, sodium hydroxide, sorbic acid, stearic acid and synthetic beeswax.</p>
<p>See crimp for lot number and expiration date.</p>
<p>Marketed by:<br>GALDERMA LABORATORIES, L.P., Fort Worth, Texas 76177 USA<br>GALDERMA is a registered trademark. P52471-0</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="L1ebdcfce-742d-4c7a-b4a4-d0eaa84d272a"></a><a name="section-11"></a><p></p>
<h1></h1>
<p class="First"><img alt="ip52460-0-desowen-lotion-4oz-carton" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=a7e5f030-b849-4805-94e6-f45631eaa37f&amp;name=p52460-0-desowen-lotion-4oz-carton.jpg"></p>
<p><span class="Bold">Rx Only NDC</span> 0299-5765-04</p>
<p>DesOwen®</p>
<p>(desonide lotion)</p>
<p>LOTION 0.05%</p>
<p>4 FL OZ</p>
<p>(118 mL)</p>
<p>P52457-0</p>
<p>GALDERMA</p>
<p><span class="Bold">FOR EXTERNAL USE ONLY. NOT FOR OPHTHALMIC USE. STORE BETWEEN 2° AND 30°C (36° AND 86°F). SHAKE WELL BEFORE USING.</span></p>
<p><span class="Bold">Usual dosage:</span> Apply a small amount to affected areas 2 or 3 times daily. See package insert for complete prescribing information.</p>
<p><span class="Bold">Contains: Active:</span> desonide 0.05% w/w (0.5 mg/g). <span class="Bold">Inactive:</span> cetyl alcohol, edetate sodium, glyceryl stearate SE, light mineral oil, methylparaben, propylene glycol, propylparaben, purified water, sodium lauryl sulfate, sorbitan monostearate, and stearyl alcohol. May contain citric acid and/or sodium hydroxide for pH adjustment. Lot number and expiration date on bottom of bottle.</p>
<p>Marketed by:<br>GALDERMA LABORATORIES, L.P.<br>Fort Worth, Texas<br>76177 USA<br>GALDERMA is a registered trademark.<br>P52458-0</p>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>DESOWEN  		
					</strong><br><span class="contentTableReg">desonide cream</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0299-5770</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">TOPICAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>Desonide</strong> (Desonide) </td>
<td class="formItem">Desonide</td>
<td class="formItem">0.5 mg  in 1 g</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>ANHYDROUS CITRIC ACID</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>Isopropyl palmitate</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Polysorbate 60</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>Potassium sorbate</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Propyl gallate</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>Propylene glycol</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Water</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>Sodium hydroxide</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Sorbic Acid</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>Stearic Acid</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0299-5770-60</td>
<td class="formItem">1  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">60 g in 1 TUBE; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:0299-5770-15</td>
<td class="formItem">1  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem"></td>
<td class="formItem">15 g in 1 TUBE; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA</td>
<td class="formItem">NDA019048</td>
<td class="formItem">12/14/1984</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>DESOWEN  		
					</strong><br><span class="contentTableReg">desonide lotion</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0299-5765</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">TOPICAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>Desonide</strong> (Desonide) </td>
<td class="formItem">Desonide</td>
<td class="formItem">0.5 mg  in 1 g</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Cetyl alcohol</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>Edetate sodium</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Glyceryl Monostearate</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>Light Mineral Oil</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Methylparaben</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>Propylene glycol</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Propylparaben</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>Water</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Sodium lauryl sulfate</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>Sorbitan monostearate</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Stearyl alcohol</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>ANHYDROUS CITRIC ACID</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Sodium hydroxide</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0299-5765-02</td>
<td class="formItem">59 g in 1 BOTTLE; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:0299-5765-04</td>
<td class="formItem">1  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem"></td>
<td class="formItem">118 g in 1 BOTTLE; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA072354</td>
<td class="formItem">07/15/1988</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Galderma Laboratories, L.P.
							(047350186)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">DPT Laboratories, Ltd.</td>
<td class="formItem"></td>
<td class="formItem">832224526</td>
<td class="formItem">MANUFACTURE(0299-5770, 0299-5765)</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 4/2015<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>b0a573ea-853c-4a47-9863-b3bedb6f41cf</div>
<div>Set id: a7e5f030-b849-4805-94e6-f45631eaa37f</div>
<div>Version: 6</div>
<div>Effective Time: 20150423</div>
</div>
</div> <div class="DistributorName">Galderma Laboratories, L.P.</div></p>
</body></html>
